Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. (trading symbol: NAOV) on May 20, 2019. The company is an emerging growth company incorporated in Delaware with principal executive offices in Elmsford, New York. The filing addresses a critical regulatory matter regarding its continued listing on the Nasdaq Capital Market.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. The primary financial metric referenced is the Nasdaq listing requirement for stockholders' equity, which must be maintained at a minimum of $2.5 million. The company's ability to meet this threshold is contingent upon securing additional funding.
Material Changes and Listing Status
On May 20, 2019, the Nasdaq Listing Qualifications Panel granted NanoVibronix, Inc. a request for continued listing. This decision was partially based on the company's assurances regarding its confidence in receiving necessary funding from investors with a history of support. The Panel maintained jurisdiction for an 180-day discretionary period, subject to specific conditions.
Outlook, Risks, and Contingencies
- Compliance Deadlines: The company must provide written updates to the Panel by June 20, 2019, and July 8, 2019, regarding its compliance plan.
- Financial Projections: By July 8, 2019, the company must submit updated pro forma financial projections demonstrating the ability to maintain stockholders' equity over $2.5 million.
- Risks: There is no assurance that the company will demonstrate compliance by the set deadlines or that the Panel will grant a further extension if compliance is not timely achieved. Failure to meet these conditions could result in delisting.
Investor Verification Checklist
- Verify the status of the funding commitments mentioned as the basis for the listing extension.
- Monitor the company's compliance updates due on June 20, 2019, and July 8, 2019.
- Review the upcoming pro forma financial projections to confirm the path to $2.5 million in stockholders' equity.
- Check for any subsequent 8-K filings regarding the Panel's evaluation of the compliance plan after the July 8 deadline.